FDA inspections 2023 - Preparing for FDA inspections
Date2023-02-13
Deadline2023-02-13
VenueOnline, USA - United States
KeywordsFDA inspections; FDA; FDA
Websitehttps://bit.ly/3kXpdye
Topics/Call fo Papers
Time and resources spent preparing for the inevitable inspection will pay back proportionately. By doing your homework and putting simple principles to work you can minimize the negative effects of the FDA’s power and put everyone in your organization at ease. By understanding the risks inherent in your products, you can develop a quality system that will align your operation with FDA’s expectations. Why live in fear when you can rest at night knowing you are ready?
WHY SHOULD YOU ATTEND?
Put yourself and your colleagues at ease by learning how to prepare for FDA,s inevitable visit. Learn how risks inherent in your product categories affect FDA behavior when they visit your firm. Mitigate those risks by anticipating FDA’s concerns. Focus on what is important! Learn how to prioritize Quality System improvements and target potential problems. How do you instill a level of control that the FDA sees as appropriate? Can you get what FDA wants in minutes? Do you understand what they are asking for? Learn how to plan for an FDA inspection and shorten the process considerably. Learn how to put your plan into action when FDA is present. You can influence FDA’s decision to take action just by how you respond to their questions. Silence is deadly, so knowing what to say and when is very important. Learn how to respond to a 483 citation. What should I do in those 15 days I have to respond? Can they take action if I do not respond? If you choke, you could be asking for more trouble.
AREA COVERED
Anticipating inspections
Preparing for an FDA audit
FDA Risk categorization
Quality Systems and Control
Importance of supplier agreements
Avoiding contract laboratory traps
Accommodating FDA during an inspection
Documenting and presenting OOS results
Sharing more information than necessary
Correcting 483 deficiencies
Learning from failures
LEARNING OBJECTIVES
Prepare for an inspection
Develop an action plan
How to react when the day comes
How to respond to a 483
Take what you learn and improve your QMS
WHO WILL BENEFIT?
Manufacturing, QA/QC, and regulatory affairs directors, managers, and supervisors
SPEAKER PROFILE
instructor
John Misock is serving in his fourth career as Senior Consultant with Ceutical Labs, Inc. Flower Mound, TX. He provides regulatory consulting services across all FDA-regulated industries. John retired from FDA in June 2019 where he was an SME in microbiological compliance and manufacturing. Prior to FDA John served in a global capacity with a multinational company responsible for regulatory compliance in all manufacturing facilities. Early in his career, John was Director of a state Food, Drug, and Cosmetics program and also served as Assistant Commissioner of Agriculture.
WHY SHOULD YOU ATTEND?
Put yourself and your colleagues at ease by learning how to prepare for FDA,s inevitable visit. Learn how risks inherent in your product categories affect FDA behavior when they visit your firm. Mitigate those risks by anticipating FDA’s concerns. Focus on what is important! Learn how to prioritize Quality System improvements and target potential problems. How do you instill a level of control that the FDA sees as appropriate? Can you get what FDA wants in minutes? Do you understand what they are asking for? Learn how to plan for an FDA inspection and shorten the process considerably. Learn how to put your plan into action when FDA is present. You can influence FDA’s decision to take action just by how you respond to their questions. Silence is deadly, so knowing what to say and when is very important. Learn how to respond to a 483 citation. What should I do in those 15 days I have to respond? Can they take action if I do not respond? If you choke, you could be asking for more trouble.
AREA COVERED
Anticipating inspections
Preparing for an FDA audit
FDA Risk categorization
Quality Systems and Control
Importance of supplier agreements
Avoiding contract laboratory traps
Accommodating FDA during an inspection
Documenting and presenting OOS results
Sharing more information than necessary
Correcting 483 deficiencies
Learning from failures
LEARNING OBJECTIVES
Prepare for an inspection
Develop an action plan
How to react when the day comes
How to respond to a 483
Take what you learn and improve your QMS
WHO WILL BENEFIT?
Manufacturing, QA/QC, and regulatory affairs directors, managers, and supervisors
SPEAKER PROFILE
instructor
John Misock is serving in his fourth career as Senior Consultant with Ceutical Labs, Inc. Flower Mound, TX. He provides regulatory consulting services across all FDA-regulated industries. John retired from FDA in June 2019 where he was an SME in microbiological compliance and manufacturing. Prior to FDA John served in a global capacity with a multinational company responsible for regulatory compliance in all manufacturing facilities. Early in his career, John was Director of a state Food, Drug, and Cosmetics program and also served as Assistant Commissioner of Agriculture.
Other CFPs
- AML Act of 2020 and the FinCEN Priorities
- 11th International Conference on Control, Mechatronics and Automation (ICCMA 2023)
- 5th International Conference on Video, Signal and Image Processing (VSIP 2023)
- 7th International Conference on Structural and Civil Engineering (ICSCE 2023)
- 7th International Conference on Building Materials and Materials Engineering (ICBMM 2023)
Last modified: 2023-02-01 14:51:25